Predictive Technology Group Inc (PRED)

[Mack Attack]

My name is Johnny Mackey https://www.linkedin.com/in/john-mackey/ and I toured Predictive Technologies biotech division escorted by Eric Olsen (President and CEO) https://www.linkedin.com/in/eric-kenneth-olson-01725396/ I did this on behalf of Thetalus Capital LLC (Managing Partner's Adam Tischer, and John Mackey. A Nevada hedge fund LLC; document # 20190251769-02).

In order to placate said Hedge investors, to which they have a fiduciary duty in their LLC because of recent naked shorts, John Mackey and Adam Tischer commissioned me to take a closer look at the company. Do they have a real location? A real product? What about the staff? Payroll? Or is it all a scam as Hindenburg et all have previously proposed.

Predictive technologies is a real company, with a real product, and real revenue. Deloitte was auditing the company even as Hindenburg was busy writing their defamatory articles and illegally shorting. It is plainly seen on the volume when these naked shorts appear. I wouldn't be surprised if legal proceedings, including jail time were in the works on behalf of Predictive and other investor's as a class action, particularly against the trade platforms and brokers facilitating them, because Predictive truly does have a stellar team. Winning awards at the ASRM conference just a few days before my tour.

Thetalus capital is in discussions to recover said money against naked shorts. The evidence they are collecting is public, and evidence is being collected against Fidelity junior broker's that have advised clients to illegally short.

While I was touring their lab (I am an analytical chemist by trade, and a subject matter expert on drug launches and FDA compliance), I saw teams of technicians and scientists busy at work cutting umblical cords to extract Stem Cells. The lab was immaculate (I was told it is ISO 5, and some parts are ISO 7 in the surrounding facilities) and the lab was in the process of obtaining more ISO certification (15189 I think Eric said?).

Most of the Board has strong connections to the University of Utah (one of the best university hospitals in the world). In fact, they share a building with the University of Utah Endocrinology and diabetes building, and have poached a large portion of their staff from former University of Utah hospital admin, taking their best and brightest.

I would estimate a payroll of about 120 employees. This does not include contract lab testing or sales staff. There were about 25-30 in the biotech building I toured busy at work (Suite 300 of 615 Arapeen Dr, Salt Lake City UT 84105)

There could be no better fit than Kenneth Ward as lab director https://www.linkedin.com/in/kenneth-ward-58201910/ , who is a long time peer of Eric Olsen as well.

While the Stem Cell pain management is the main source of revenue for Predictive, there have been an enormous amount of public announcements about Endometriosis products, including Fertility DX, and the ARTguide. A spirit of optimism abounds in the building.

Eric couldn't give out non-public information about sales, but optimism by him and the staff abounds. I was told to pay close attention to the next 10K filings about their newer products sales trajectories.

Of particular interest to Thetalus Capital has been the CLSA venture into China announced 10/15. This hard to reach exclusive market could prove extremely valuable to Predictive Technologies as they are the first endometriosis treatment "in" inside the country of any substance. This was quite a hat trick indeed.

As much as Eric Olsen was able to disclose, their Nasdaq listing is on track. They anticipate it shortly after they can get the stock to close above the required price. Deloitte has been instrumental in helping their Nasdaq listing, and making sure they are ready to go once the trigger has been pulled.

My recommendation as a scientist in pharmaceuticals was to maintain or even increase Thetalus's capital's position (The LLC has operating agreement rules that limit their investments as a %, but with the decrease in price may allow them to increase their position). Stem cell pain management will grow exponentially (10K filings of PRED show a 160% or more growth for a large company.) As this explosive growth trading at 10x Sales of a growth company is a no brainer.

I witnessed Umblical Cord splicing. These technicians weren't putting on a show (I interned at the University of Utah's medical lab testing ARUP Clinical Toxicology 3 lab under Chantry Clark https://www.linkedin.com/in/chantry-clark-18739878/ , which included Umbilical cord slicing)

This complicated business is being navigated successfully by the PRED staff. Most had MBA's, MHA's, MD's and other accreditation's.

World class staff. Couldn't be run by anyone better.

I would advise the shorts: prepare for poverty and jail time.